Omeros (OMER) Non-Current Debt (2010 - 2026)
Omeros recorded quarterly Non-Current Debt of $52.8 million in Q1 2026, up 2.82% quarter-over-quarter from $51.4 million in Q4 2025, and down 24.98% year-over-year from $70.4 million in Q1 2025.
Omeros' Non-Current Debt history runs 17 years deep, the most recent figure standing at $52.8 million for Q1 2026.
- In Q1 2026, Non-Current Debt fell 24.98% year-over-year to $52.8 million; the TTM figure through Mar 2026 stood at $52.8 million (down 24.98% YoY), while the FY2025 annual figure was $51.4 million, down 26.24% from the prior year.
- Non-Current Debt came in at $52.8 million for Q1 2026 at Omeros, up from $51.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $314.8 million in Q3 2022 to a low of $51.4 million in Q4 2025.
- A 5-year average of $167.4 million and a median of $213.2 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt increased 0.58% in 2022 and plunged 67.33% in 2024, its largest moves.
- Omeros' Non-Current Debt stood at $220.9 million in 2022, then decreased by 3.51% to $213.2 million in 2023, then slumped by 67.33% to $69.6 million in 2024, then declined by 26.24% to $51.4 million in 2025, then grew by 2.82% to $52.8 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $52.8 million, $51.4 million, and $72.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 52.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.81 Mn |
| Mar 31, 2026 | 52.81 Mn |
| Dec 31, 2025 | 51.36 Mn |
| Dec 31, 2025 | 51.36 Mn |
| Sep 30, 2025 | 72.08 Mn |
| Sep 30, 2025 | 72.08 Mn |
| Jun 30, 2025 | 87.31 Mn |
| Jun 30, 2025 | 87.31 Mn |
| Mar 31, 2025 | 70.40 Mn |
| Mar 31, 2025 | 70.40 Mn |
| Dec 31, 2024 | 69.64 Mn |
| Dec 31, 2024 | 69.64 Mn |
| Sep 30, 2024 | 92.43 Mn |
| Sep 30, 2024 | 92.43 Mn |
| Jun 30, 2024 | 94.51 Mn |
| Jun 30, 2024 | 94.51 Mn |
| Mar 31, 2024 | 213.46 Mn |
| Mar 31, 2024 | 213.46 Mn |
| Dec 31, 2023 | 213.16 Mn |
| Dec 31, 2023 | 213.16 Mn |
| Sep 30, 2023 | 221.83 Mn |
| Sep 30, 2023 | 221.83 Mn |
| Jun 30, 2023 | 221.52 Mn |
| Jun 30, 2023 | 221.52 Mn |
| Mar 31, 2023 | 221.21 Mn |
| Mar 31, 2023 | 221.21 Mn |
| Dec 31, 2022 | 220.91 Mn |
| Dec 31, 2022 | 220.91 Mn |
| Sep 30, 2022 | 314.82 Mn |
| Sep 30, 2022 | 314.82 Mn |
| Jun 30, 2022 | 314.36 Mn |
| Jun 30, 2022 | 314.36 Mn |
| Mar 31, 2022 | 313.90 Mn |
| Mar 31, 2022 | 313.90 Mn |
| Dec 31, 2021 | 313.46 Mn |
| Dec 31, 2021 | 313.46 Mn |
| Sep 30, 2021 | 313.02 Mn |
| Sep 30, 2021 | 313.02 Mn |
| Jun 30, 2021 | 312.59 Mn |
| Jun 30, 2021 | 312.59 Mn |
| Mar 31, 2021 | 312.16 Mn |
| Mar 31, 2021 | 312.16 Mn |
| Dec 31, 2020 | 236.29 Mn |
| Dec 31, 2020 | 236.29 Mn |
| Sep 30, 2020 | 232.81 Mn |
| Sep 30, 2020 | 232.81 Mn |
| Jun 30, 2020 | 163.37 Mn |
| Jun 30, 2020 | 163.37 Mn |
| Mar 31, 2020 | 160.75 Mn |
| Mar 31, 2020 | 160.75 Mn |
| Dec 31, 2019 | 158.21 Mn |
| Dec 31, 2019 | 158.21 Mn |
| Sep 30, 2019 | 155.77 Mn |
| Sep 30, 2019 | 155.77 Mn |
| Jun 30, 2019 | 153.42 Mn |
| Jun 30, 2019 | 153.42 Mn |
| Mar 31, 2019 | 151.18 Mn |
| Mar 31, 2019 | 151.18 Mn |
| Dec 31, 2018 | 148.98 Mn |
| Dec 31, 2018 | 148.98 Mn |
| Sep 30, 2018 | 131.70 Mn |
| Sep 30, 2018 | 131.70 Mn |
| Jun 30, 2018 | 129.75 Mn |
| Jun 30, 2018 | 129.75 Mn |
| Mar 31, 2018 | 85.04 Mn |
| Mar 31, 2018 | 85.04 Mn |
| Dec 31, 2017 | 83.31 Mn |
| Dec 31, 2017 | 83.31 Mn |
| Sep 30, 2017 | 82.78 Mn |
| Sep 30, 2017 | 82.78 Mn |
| Jun 30, 2017 | 81.51 Mn |
| Jun 30, 2017 | 81.51 Mn |
| Mar 31, 2017 | 80.50 Mn |
| Mar 31, 2017 | 80.50 Mn |
| Dec 31, 2016 | 79.51 Mn |
| Dec 31, 2016 | 79.51 Mn |
| Sep 30, 2016 | 70.29 Mn |
| Sep 30, 2016 | 70.29 Mn |
| Jun 30, 2016 | 69.83 Mn |
| Jun 30, 2016 | 69.83 Mn |
| Mar 31, 2016 | 49.97 Mn |
| Mar 31, 2016 | 49.97 Mn |
| Dec 31, 2015 | 49.77 Mn |
| Dec 31, 2015 | 49.77 Mn |
| Sep 30, 2015 | 18.97 Mn |
| Sep 30, 2015 | 18.97 Mn |
| Jun 30, 2015 | 21.48 Mn |
| Jun 30, 2015 | 21.48 Mn |
| Mar 31, 2015 | 23.91 Mn |
| Mar 31, 2015 | 23.91 Mn |
| Dec 31, 2014 | 26.12 Mn |
| Dec 31, 2014 | 26.12 Mn |
| Sep 30, 2014 | 28.55 Mn |
| Sep 30, 2014 | 28.55 Mn |
| Jun 30, 2014 | 30.76 Mn |
| Jun 30, 2014 | 30.76 Mn |
| Mar 31, 2014 | 32.21 Mn |
| Mar 31, 2014 | 32.21 Mn |
| Dec 31, 2013 | 14.90 Mn |
| Dec 31, 2013 | 14.90 Mn |
| Sep 30, 2013 | 16.38 Mn |
| Sep 30, 2013 | 16.38 Mn |
| Jun 30, 2013 | 17.81 Mn |
| Jun 30, 2013 | 17.81 Mn |
| Mar 31, 2013 | 19.20 Mn |
| Mar 31, 2013 | 19.20 Mn |
| Dec 31, 2012 | 20.10 Mn |
| Dec 31, 2012 | 20.10 Mn |
| Sep 30, 2012 | 8.68 Mn |
| Sep 30, 2012 | 8.68 Mn |
| Jun 30, 2012 | 10.35 Mn |
| Jun 30, 2012 | 10.35 Mn |
| Mar 31, 2012 | 11.97 Mn |
| Mar 31, 2012 | 11.97 Mn |
| Dec 31, 2011 | 13.55 Mn |
| Dec 31, 2011 | 13.55 Mn |
| Sep 30, 2011 | 15.09 Mn |
| Sep 30, 2011 | 15.09 Mn |
| Jun 30, 2011 | 16.59 Mn |
| Jun 30, 2011 | 16.59 Mn |
| Dec 31, 2010 | 9.86 Mn |
| Dec 31, 2010 | 9.86 Mn |